Logo-apb
Adv Pharm Bull. 2024;14(3): 604-612. doi: 10.34172/apb.2024.055
PMID: 39494258        PMCID: PMC11530885

Mini Review

Cytobiological Alterations Induced by Celecoxib as an Anticancer Agent for Breast and Metastatic Breast Cancer

Maher Monir. Akl 1 * ORCID, Amr Ahmed 2 ORCID

Cited by CrossRef: 0


1- Bai C, Xu X, Zhang J, Li X, Zhang T. A Rapid and Sensitive Supercritical Fluid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Celecoxib in Beagle Plasma: Application to Pharmacokinetic Studies. Separation Science Plus. 2025;8(4) [Crossref]
2- Abdel-Aziz A, El-Azab A, Brogi S, Ayyad R, Al-Suwaidan I, Hefnawy M. Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study. IJMS. 2024;25(24):13621 [Crossref]
3- Shi P, Xu J, Cui H. Targeting oxygenases could be a viable anti-metastatic approach in cancer therapy. International Journal of Biological Macromolecules. 2025;:143375 [Crossref]